Mourning the passing of Dr. Eugene Braunwald

From the Latin American Society of Interventional Cardiology (SOLACI), we deeply regret the passing of Dr. Eugene Braunwald, a central figure in the development of contemporary cardiology and an undisputed reference in cardiovascular medicine worldwide.

His vast knowledge, tireless dedication to research, and invaluable legacy have impacted generations of students and professionals around the world.

At SOLACI, we wish to express our deepest recognition and respect for his extraordinary contribution to the advancement of cardiology. His scientific contributions and vision have accompanied, influenced, and supported many of the most relevant and transformative developments in interventional cardiology.

We extend our most sincere condolences to his family, colleagues, and loved ones during this time of profound sorrow.

More articles by this author

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

Institutional Statement: SOLACI Expresses Its Solidarity with the People of Venezuela

The Latin American Society of Interventional Cardiology (SOLACI) expresses its deepest sorrow over the consequences of the earthquake that has affected Venezuela. We stand in...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...